Tags

Type your tag names separated by a space and hit enter

[Congenital junctional ectopic tachycardia. Pharmacologic management during infancy].
Medicina (B Aires) 2011; 71(6):521-4M

Abstract

Congenital junctional ectopic tachycardia (JET) is a rare arrhythmia that can be refractory to medical therapy with high morbidity and mortality rates. The aim of this study was to report our experience with pharmacologic management of congenital JET in infants. Seven patients with congenital JET were identified between 2008 and 2010. Only two of them presented dilated cardiomyopathy. There were no congenital structural defects. Amiodarone was given to all the patients, as single therapy in one, and in combination with propranolol in four. In one patient flecainide was administered together with amiodarone and propranolol, and in another patient was used combined with amiodarone. During follow- up with an average time of 12.2 months (median 9.75 months, range 1-28 months), sinus rhythm alternating with slow junctional tachycardia was successfully achieved in 3 patients; no side effects were detected. There was only one death in our study group. The combination of different antiarrhythmics (amiodarone plus propranolol, and eventually flecainide) is a valid option for rhythm control and management of JET in infants.

Authors+Show Affiliations

Servicio de Cardiología Pediátrica, Hospital de Niños de Córdoba, Buenos Aires, Argentina. monibenjamin@hotmail.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't

Language

spa

PubMed ID

22167724

Citation

Benjamín, Mónica N., et al. "[Congenital Junctional Ectopic Tachycardia. Pharmacologic Management During Infancy]." Medicina, vol. 71, no. 6, 2011, pp. 521-4.
Benjamín MN, Infante J, Olmedo J, et al. [Congenital junctional ectopic tachycardia. Pharmacologic management during infancy]. Medicina (B Aires). 2011;71(6):521-4.
Benjamín, M. N., Infante, J., Olmedo, J., Abello, M., & Moltedo, J. M. (2011). [Congenital junctional ectopic tachycardia. Pharmacologic management during infancy]. Medicina, 71(6), pp. 521-4.
Benjamín MN, et al. [Congenital Junctional Ectopic Tachycardia. Pharmacologic Management During Infancy]. Medicina (B Aires). 2011;71(6):521-4. PubMed PMID: 22167724.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Congenital junctional ectopic tachycardia. Pharmacologic management during infancy]. AU - Benjamín,Mónica N, AU - Infante,Juan, AU - Olmedo,Julián, AU - Abello,Mauricio, AU - Moltedo,José M, PY - 2011/12/15/entrez PY - 2011/12/15/pubmed PY - 2014/9/23/medline SP - 521 EP - 4 JF - Medicina JO - Medicina (B Aires) VL - 71 IS - 6 N2 - Congenital junctional ectopic tachycardia (JET) is a rare arrhythmia that can be refractory to medical therapy with high morbidity and mortality rates. The aim of this study was to report our experience with pharmacologic management of congenital JET in infants. Seven patients with congenital JET were identified between 2008 and 2010. Only two of them presented dilated cardiomyopathy. There were no congenital structural defects. Amiodarone was given to all the patients, as single therapy in one, and in combination with propranolol in four. In one patient flecainide was administered together with amiodarone and propranolol, and in another patient was used combined with amiodarone. During follow- up with an average time of 12.2 months (median 9.75 months, range 1-28 months), sinus rhythm alternating with slow junctional tachycardia was successfully achieved in 3 patients; no side effects were detected. There was only one death in our study group. The combination of different antiarrhythmics (amiodarone plus propranolol, and eventually flecainide) is a valid option for rhythm control and management of JET in infants. SN - 0025-7680 UR - https://www.unboundmedicine.com/medline/citation/22167724/[Congenital_junctional_ectopic_tachycardia__Pharmacologic_management_during_infancy]_ DB - PRIME DP - Unbound Medicine ER -